Moderna sues Pfizer and BioNTech for mRNA patent infringement
CAMBRIDGE, MA, August 27, 2022—Moderna, Inc., a $53.5 billion biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, filed patent
Read MoreCAMBRIDGE, MA, August 27, 2022—Moderna, Inc., a $53.5 billion biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, filed patent
Read More